We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.5%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$3.64B
AUM Growth
+$1.11B
Cap. Flow
+$1.01B
Cap. Flow %
27.59%
Top 10 Hldgs %
15.73%
Holding
482
New
187
Increased
74
Reduced
47
Closed
168

Sector Composition

Rank Sector Weight
1 Healthcare 13.3%
2 Industrials 13.08%
3 Financials 11.22%
4 Energy 7.46%
5 Consumer Staples 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATRC icon
201
AtriCure
ATRC
$2.11B
$4.69M 0.13%
+249,310
New +$5.11M
IBTX
202
DELISTED
Independent Bank Group, Inc.
IBTX
$4.65M 0.13%
79,205
+19,205
+32% +$1.02M
DVN icon
203
Devon Energy
DVN
$47.3B
$4.64M 0.13%
69,308
-171,126
-71% -$10.6M
RALY
204
DELISTED
RALLY SOFTWARE DEV CORP
RALY
$4.64M 0.13%
346,609
-69,812
-17% -$1.39M
MNDT
205
DELISTED
Mandiant, Inc. Common Stock
MNDT
$4.62M 0.13%
75,000
+43,414
+137% +$3.08M
MON
206
DELISTED
Monsanto Co
MON
$4.51M 0.12%
39,665
-160,335
-80% -$17.8M
BV
207
DELISTED
Bazaarvoice, Inc.
BV
$4.49M 0.12%
615,336
+188,367
+44% +$1.42M
CVRR
208
DELISTED
CVR Refining, LP
CVRR
$4.46M 0.12%
191,680
+49,752
+35% +$1.11M
AMID
209
DELISTED
American Midstream Partners, LP
AMID
$4.46M 0.12%
+175,000
New +$4.46M
TBRA
210
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$4.45M 0.12%
39,454
+26,563
+206% +$1.86M
VZ icon
211
Verizon
VZ
$196B
$4.41M 0.12%
+92,717
New +$4.38M
CNQ icon
212
CALL
Canadian Natural Resources
CNQ
$93.8B
$4.31M 0.12%
+232,505
New +$3.93M
RKT
213
DELISTED
ROCK-TENN COMPANY CL-A
RKT
$4.27M 0.12%
+80,920
New +$4.24M
GLNG icon
214
Golar LNG
GLNG
$5.13B
$4.23M 0.12%
101,374
-249,838
-71% -$9.25M
BX icon
215
Blackstone
BX
$110B
$4.17M 0.11%
127,947
-104,926
-45% -$3.35M
ENZY
216
DELISTED
Enzymotec Ltd
ENZY
$4.08M 0.11%
+185,533
New +$4.92M
ASC icon
217
Ardmore Shipping
ASC
$683M
$4M 0.11%
300,501
+83,796
+39% +$1.17M
HAL icon
218
CALL
Halliburton
HAL
$26.6B
$3.98M 0.11%
+67,600
New +$3.61M
CNCE
219
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$3.94M 0.11%
+292,773
New +$4.13M
WLL
220
DELISTED
Whiting Petroleum Corporation
WLL
$3.9M 0.11%
187
+104
+125% +$1.97M
WINT
221
DELISTED
Windtree Therapeutics Inc
WINT
$3.89M 0.11%
129,270
+38,999
+43% +$1.31M
GNMK
222
DELISTED
GenMark Diagnostics, Inc
GNMK
$3.8M 0.1%
382,724
+129,856
+51% +$1.61M
CNX icon
223
CNX Resources
CNX
$5.2B
$3.75M 0.1%
+112,547
New +$3.63M
MBII
224
DELISTED
Marrone Bio Innovations, Inc.
MBII
$3.73M 0.1%
266,991
+60,273
+29% +$947K
ITCI
225
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.54M 0.1%
+194,563
New +$3.51M

Similar funds

Alyeska Investment Group's Q1 2014 Portfolio in Review

As of Q1 2014, Alyeska Investment Group held 482 positions worth $3.64B, up 44% from $2.53B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group deployed $1.01B of net new capital in Q1 2014, opening 187 new positions and adding to 74 existing holdings. Its largest new stake was Netflix: 5,600,000 shares worth $28.2M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was NorthStar Realty Finance Corp., an estimated $34.5M trimmed.

  • Alyeska Investment Group's largest Q1 2014 buy was Netflix: 5,600,000 shares worth $28.2M.
  • Alyeska Investment Group added most to Bloomin' Brands in Q1 2014, an estimated $58.4M increase.
  • Alyeska Investment Group's biggest Q1 2014 reduction was NorthStar Realty Finance Corp., cutting an estimated $34.5M.
  • Alyeska Investment Group fully exited 3M in Q1 2014, selling an estimated $36.5M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $3.64B portfolio in Q1 2014.
  • Alyeska Investment Group opened 187 new positions and closed 168 in Q1 2014.
  • Alyeska Investment Group's portfolio value rose 44% quarter-over-quarter to $3.64B.

Based on Alyeska Investment Group's 13F filing for Q1 2014, filed 15 May 2014.